Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 12
2005 2
2006 1
2007 1
2008 4
2009 12
2010 7
2011 6
2012 22
2013 17
2014 21
2015 12
2016 19
2017 17
2018 20
2019 22
2020 28
2021 52
2022 48
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 19910433

263 results
Results by year
Filters applied: . Clear all
Page 1
Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer.
Behr SC, Aggarwal R, VanBrocklin HF, Flavell RR, Gao K, Small EJ, Blecha J, Jivan S, Hope TA, Simko JP, Kurhanewicz J, Noworolski SM, Korn NJ, De Los Santos R, Cooperberg MR, Carroll PR, Nguyen HG, Greene KL, Langton-Webster B, Berkman CE, Seo Y. Behr SC, et al. J Nucl Med. 2019 Jul;60(7):910-916. doi: 10.2967/jnumed.118.220715. Epub 2018 Nov 21. J Nucl Med. 2019. PMID: 30464040 Free PMC article. Clinical Trial.
Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer.
Dannoon S, Ganguly T, Cahaya H, Geruntho JJ, Galliher MS, Beyer SK, Choy CJ, Hopkins MR, Regan M, Blecha JE, Skultetyova L, Drake CR, Jivan S, Barinka C, Jones EF, Berkman CE, VanBrocklin HF. Dannoon S, et al. J Med Chem. 2016 Jun 23;59(12):5684-94. doi: 10.1021/acs.jmedchem.5b01850. Epub 2016 Jun 13. J Med Chem. 2016. PMID: 27228467 Free PMC article.
263 results